Propofol reduces human TRPA1 activity in a warm environment.

Area of Science:

• Anesthesiology
• Neuroscience
• Pharmacology

Background:

• Propofol, an intravenous anesthetic, commonly causes vascular pain upon injection.
• This pain is linked to the activation of transient receptor potential ankyrin1 (TRPA1) channels in sensory nerve endings.
• Current methods to mitigate this side effect are insufficient.

Purpose of the Study:

• To investigate the effect of propofol temperature on human TRPA1 (hTRPA1) channel activation.
• To determine if temperature modulation of propofol can reduce vascular pain without compromising anesthetic effects.

Main Methods:

• HEK293T cells expressing hTRPA1 were utilized.
• The patch-clamp technique was employed to measure hTRPA1 activity.
• Responses to cooled and heated propofol were assessed.

Main Results:

• Warming propofol to above 35°C significantly reduced hTRPA1 channel currents.
• Heated propofol inhibited hTRPA1 activation.
• Propofol's effect on human GABA_A receptors, crucial for anesthesia, remained unaltered.

Conclusions:

• Maintaining propofol temperature above 35°C may minimize hTRPA1 activation.
• Heated propofol shows potential for reducing vascular pain associated with anesthesia.
• This approach offers a strategy to alleviate propofol-induced pain without compromising its efficacy.